559 related articles for article (PubMed ID: 1380674)
21. Characterization of endogenous peptides bound to purified HLA-DR molecules and their absence from invariant chain-associated alpha beta dimers.
Newcomb JR; Cresswell P
J Immunol; 1993 Jan; 150(2):499-507. PubMed ID: 8419482
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the N-linked glycopeptides of DQw1 and DR1 molecules.
Iturbe S; Narasimhan S; Merrick JM; Falk JA; Letarte M
J Immunol; 1986 Jun; 136(12):4588-95. PubMed ID: 3486905
[TBL] [Abstract][Full Text] [Related]
23. Variation in HLA-DM expression influences conversion of MHC class II alpha beta:class II-associated invariant chain peptide complexes to mature peptide-bound class II alpha beta dimers in a normal B cell line.
Ramachandra L; Kovats S; Eastman S; Rudensky AY
J Immunol; 1996 Mar; 156(6):2196 - 2204. PubMed ID: 8690909
[TBL] [Abstract][Full Text] [Related]
24. Random association between the peptide repertoire of A2.1 class I and several different DR class II molecules.
Sette A; Vitiello A; Farness P; Furze J; Sidney J; Claverie JM; Grey HM; Chesnut R
J Immunol; 1991 Dec; 147(11):3893-900. PubMed ID: 1658152
[TBL] [Abstract][Full Text] [Related]
25. Identification of an HLA-DQ2 peptide binding motif and HLA-DPw3-bound self-peptide by pool sequencing.
Verreck FA; van de Poel A; Termijtelen A; Amons R; Drijfhout JW; Koning F
Eur J Immunol; 1994 Feb; 24(2):375-9. PubMed ID: 8299686
[TBL] [Abstract][Full Text] [Related]
26. Functional analysis of DR17(DR3)-restricted mycobacterial T cell epitopes reveals DR17-binding motif and enables the design of allele-specific competitor peptides.
Geluk A; Van Meijgaarden KE; Janson AA; Drijfhout JW; Meloen RH; De Vries RR; Ottenhoff TH
J Immunol; 1992 Nov; 149(9):2864-71. PubMed ID: 1383331
[TBL] [Abstract][Full Text] [Related]
27. Interference of distinct invariant chain regions with superantigen contact area and antigenic peptide binding groove of HLA-DR.
Vogt AB; Stern LJ; Amshoff C; Dobberstein B; Hämmerling GJ; Kropshofer H
J Immunol; 1995 Nov; 155(10):4757-65. PubMed ID: 7594477
[TBL] [Abstract][Full Text] [Related]
28. [Analysis of the allele specific Ag-binding site on murine class II MHC].
Kajino K
Hokkaido Igaku Zasshi; 1996 Mar; 71(2):187-203. PubMed ID: 8641675
[TBL] [Abstract][Full Text] [Related]
29. Definition of specific peptide motifs for four major HLA-A alleles.
Kubo RT; Sette A; Grey HM; Appella E; Sakaguchi K; Zhu NZ; Arnott D; Sherman N; Shabanowitz J; Michel H
J Immunol; 1994 Apr; 152(8):3913-24. PubMed ID: 8144960
[TBL] [Abstract][Full Text] [Related]
30. Binding motifs of copolymer 1 to multiple sclerosis- and rheumatoid arthritis-associated HLA-DR molecules.
Fridkis-Hareli M; Neveu JM; Robinson RA; Lane WS; Gauthier L; Wucherpfennig KW; Sela M; Strominger JL
J Immunol; 1999 Apr; 162(8):4697-704. PubMed ID: 10202010
[TBL] [Abstract][Full Text] [Related]
31. Differential effect of polymorphism at HLA-DR1 beta-chain positions 85 and 86 on binding and recognition of DR1-restricted antigenic peptides.
Newton-Nash DK; Eckels DD
J Immunol; 1993 Mar; 150(5):1813-21. PubMed ID: 7679697
[TBL] [Abstract][Full Text] [Related]
32. Naturally processed cytokine-derived peptide bound to HLA-class II molecules.
Harris PE; Maffei A; Liu Z; Colovai I; Reed EF; Inghirami G; Suciu-Foca N
J Immunol; 1993 Dec; 151(11):5975-83. PubMed ID: 8245442
[TBL] [Abstract][Full Text] [Related]
33. Analysis of allele-specific contact sites of natural HLA-DR17 ligands.
Malcherek G; Gnau V; Stevanovic S; Rammensee HG; Jung G; Melms A
J Immunol; 1994 Aug; 153(3):1141-9. PubMed ID: 8027545
[TBL] [Abstract][Full Text] [Related]
34. Differences in MHC class I self peptide repertoires among HLA-A2 subtypes.
Sudo T; Kamikawaji N; Kimura A; Date Y; Savoie CJ; Nakashima H; Furuichi E; Kuhara S; Sasazuki T
J Immunol; 1995 Nov; 155(10):4749-56. PubMed ID: 7594476
[TBL] [Abstract][Full Text] [Related]
35. Peptide linkage to the α-subunit of MHCII creates a stably inverted antigen presentation complex.
Schlundt A; Günther S; Sticht J; Wieczorek M; Roske Y; Heinemann U; Freund C
J Mol Biol; 2012 Oct; 423(3):294-302. PubMed ID: 22820093
[TBL] [Abstract][Full Text] [Related]
36. Sequence motifs important for peptide binding to the human MHC class I molecule, HLA-A2.
Parker KC; Bednarek MA; Hull LK; Utz U; Cunningham B; Zweerink HJ; Biddison WE; Coligan JE
J Immunol; 1992 Dec; 149(11):3580-7. PubMed ID: 1331239
[TBL] [Abstract][Full Text] [Related]
37. Determination of the allele-specific antigen-binding site on I-Ak and I-Ab molecules.
Itoh Y; Kajino K; Ogasawara K; Katoh M; Namba K; Takami K; Iwabuchi K; Braunstein NS; Onoé K
Eur J Immunol; 1996 Jun; 26(6):1314-21. PubMed ID: 8647211
[TBL] [Abstract][Full Text] [Related]
38. Supermotifs enable natural invariant chain-derived peptides to interact with many major histocompatibility complex-class II molecules.
Malcherek G; Gnau V; Jung G; Rammensee HG; Melms A
J Exp Med; 1995 Feb; 181(2):527-36. PubMed ID: 7836909
[TBL] [Abstract][Full Text] [Related]
39. Selective release of some invariant chain-derived peptides from HLA-DR1 molecules at endosomal pH.
Urban RG; Chicz RM; Strominger JL
J Exp Med; 1994 Aug; 180(2):751-5. PubMed ID: 8046351
[TBL] [Abstract][Full Text] [Related]
40. N-terminal elongation of a peptide determinant beyond the first primary anchor improves binding to H-2 I-Ad and HLA-DR1 by backbone-dependent and aromatic side chain-dependent interactions, respectively.
Bartnes K; Leon F; Briand JP; Travers PJ; Hannestad K
Eur J Immunol; 1999 Jan; 29(1):189-95. PubMed ID: 9933100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]